Legacy Wealth Management (Idaho)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-195
Closed -$68.6K 227
2026
Q1
$68.6K Buy
195
+8
+4% +$2.85K 0.03% 227
2025
Q4
$61.2K Buy
187
+91
+95% +$28.9K 0.03% 193
2025
Q3
$27.1K Hold
96
0.01% 238
2025
Q2
$26.8K Sell
96
-3
-3% -$850 0.01% 212
2025
Q1
$30.8K Sell
99
-42
-30% -$12.4K 0.02% 191
2024
Q4
$41.4K Buy
141
+45
+47% +$13.4K 0.03% 139
2024
Q3
$28.9K Buy
+96
New +$31.4K 0.02% 166

Other funds holding AMGN

Legacy Wealth Management (Idaho)'s AMGN Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Amgen (AMGN) in Q2 2026, closing a stake of 195 shares — an estimated $68.6K sold.

Legacy Wealth Management (Idaho) first reported a position in AMGN in Q3 2024 and held it in 7 quarters. The position peaked at $68.6K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 195 Amgen shares in Q2 2026, an estimated $68.6K.
  • Legacy Wealth Management (Idaho) first reported a position in Amgen in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Amgen position peaked at $68.6K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.